Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia
- 26 May 2025
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 39 (8) , 2039-2041
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasmsBlood Cancer Journal, 2024
- [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].2023
- Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical PracticeClinical Lymphoma Myeloma and Leukemia, 2023
- More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple MyelomaJournal of Clinical Oncology, 2023
- Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and MoreJournal of Clinical Oncology, 2023
- Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time?Journal of Clinical Oncology, 2022
- Multiple myeloma with t(11;14): unique biology and evolving landscape2022
- Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentageBlood Cancer Journal, 2021
- Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cellsAmerican Journal of Hematology, 2019
- STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaborationBMJ Open, 2016